BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 50 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q2 2024. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 7,917,653 | $2,680,126 | 0.03% |
| Weaver Consulting Group | 234,356 | $79,330 | 0.03% |
| LIBERTY WEALTH MANAGEMENT LLC | 340,150 | $115 | 0.02% |
| ABNER HERRMAN & BROCK LLC | 145,500 | $49 | 0.01% |
| Saxony Capital Management, LLC | 12,950 | $4,384 | 0.01% |
| Ikarian Capital, LLC | 90,242 | $30,547 | 0.01% |
| JMAC ENTERPRISES LLC | 65,430 | $22,148 | 0.00% |
| First Affirmative Financial Network | 14,293 | $4,838 | 0.00% |
| Professional Financial Advisors, LLC | 17,279 | $5,849 | 0.00% |
| Virtu Financial LLC | 49,586 | $17 | 0.00% |
| Activest Wealth Management | 7,080 | $2,397 | 0.00% |
| ST GERMAIN D J CO INC | 500 | $169 | 0.00% |
| Clearstead Advisors, LLC | 1,500 | $508 | 0.00% |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 6,000 | $2,031 | 0.00% |
| OSAIC HOLDINGS, INC. | 10,519 | $3,576 | 0.00% |
| VisionPoint Advisory Group, LLC | 1,944 | $658 | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 161 | $55 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 364 | $123 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 484,285 | $163,986 | 0.00% |
| Janney Montgomery Scott LLC | 20,500 | $7 | 0.00% |
External links
This page lists BRAINSTORM CELL THERAPEUTICS's shareholders in Q2 2024. To view BRAINSTORM CELL THERAPEUTICS's shareholder history, click here.